Annals of Surgical Oncology

, Volume 18, Issue 9, pp 2453–2460 | Cite as

Can Lymph Node Ratio Take the Place of pN Categories in the UICC/AJCC TNM Classification System for Colorectal Cancer?

  • Lin-lin Tong
  • Peng Gao
  • Zhen-ning Wang
  • Yong-xi Song
  • Ying-ying Xu
  • Zhe Sun
  • Cheng-zhong Xing
  • Xin Wang
  • Hui-mian Xu
Colorectal Cancer

Abstract

Background

Lymph node ratio (LNR) has been reported to represent a powerful independent prognostic value in some malignancies. The significance of LNR in colorectal cancer is still under debate.

Methods

A total of 505 patients with stage III colorectal cancer were reviewed. Using running log-rank statistics, we calculated the best cutoff values for LNRs and proposed a novel rN category: rN1, 0% < LNR ≤ 35%; rN2, 35% < LNR ≤ 69%; and rN3, LNR > 69%. A Spearman’s correlation coefficient test was used to assess the correlation between the number of retrieved nodes and the number of metastatic nodes, as well as the number of retrieved nodes and the LNRs. Univariate and two-step multivariate analyses were performed, respectively, to identify the significant prognostic clinicopathologic factors.

Results

The 5-year overall survival rate decreased significantly with increasing LNRs: rN1 = 61% survival rate, rN2 = 30.3% survival rate, and rN3 = 11.2% survival rate (P < 0.001). Univariate and two-step multivariate analyses identified the rN category as a significant prognostic factor no matter whether the minimum number of LNs retrieved was met. There was a significant prognostic difference among different rN categories for any pN category, but no apparent prognostic difference was seen between different pN categories in any rN category. Moreover, marked heterogeneity could be seen within IIIa–c substages when survival was compared among rN1–3 categories but not between pN1–2 categories.

Conclusions

rN categories have more potential for predicting patient outcomes and are superior to the UICC/AJCC pN categories. We recommend rN categories for prognostic assessment and rN categories should be reported routinely in histopathological reports.

References

  1. 1.
    Ostadi MA, Harnish JL, Stegienko S, Urbach DR. Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc. 2007;21:2142–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Greene FL. Current TNM staging of colorectal cancer. Lancet Oncol. 2007;8:572–3.PubMedCrossRefGoogle Scholar
  3. 3.
    O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Wong KP, Poon JT, Fan JK, Law WL. Prognostic value of lymph node ratio in stage III colorectal cancer. Colorectal Dis. doi:10.1111/j.1463-1318.2010.02435.x.
  5. 5.
    Ceelen W, Van Nieuwenhove Y, Pattyn P. Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol. 2010;17:2847–55.PubMedCrossRefGoogle Scholar
  6. 6.
    Kehoe J, Khatri VP. Staging and prognosis of colon cancer. Surg Oncol Clin N Am. 2006;15:129–46.PubMedCrossRefGoogle Scholar
  7. 7.
    Derwinger K, Carlsson G, Gustavsson B. A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol. 2008;34:771–5.PubMedGoogle Scholar
  8. 8.
    Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol. 2004;70:225–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Berger AC, Watson JC, Ross EA, Hoffman JP. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2004;70:235–40; discussion 240.PubMedGoogle Scholar
  10. 10.
    Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;9:27–34.PubMedCrossRefGoogle Scholar
  11. 11.
    Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706–12.PubMedCrossRefGoogle Scholar
  12. 12.
    Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, Kim C. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol. 2007;14:1712–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Wang J, Hassett JM, Dayton MT, Kulaylat MN. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2008;15:1600–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol. 2003;10:1077–85.PubMedCrossRefGoogle Scholar
  15. 15.
    Sun Z, Zhu GL, Lu C, et al. The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients. Ann Oncol. 2009;20:897–905.PubMedCrossRefGoogle Scholar
  16. 16.
    Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  17. 17.
    Chok KS, Law WL. Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg. 2007;31:1485–90.PubMedCrossRefGoogle Scholar
  18. 18.
    Sun Z, Zhu GL, Lu C, et al. A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa. Ann Surg. 2009;249:768–75.PubMedCrossRefGoogle Scholar
  19. 19.
    Takahashi H, Kurishima K, Ishikawa H, Kagohashi K, Kawaguchi M, Satoh H. Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running statistical analysis. Anticancer Res. 2010;30:3833–7.PubMedGoogle Scholar
  20. 20.
    Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM classification on malignant tumours. 5th ed. New York: Wiley-Liss; 1997.Google Scholar
  21. 21.
    Sobin LH, Wittekind CH, International Union Against Cancer (UICC). TNM classification on malignant tumours. 6th ed. New York: Wiley-Liss; 2002.Google Scholar
  22. 22.
    Huh JW, Kim YJ, Kim HR. Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Ann Surg Oncol. 2010;17:2640–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Hong KD, Lee SI, Moon HY. Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancer. J Surg Oncol. 2011;103:406–10.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2011

Authors and Affiliations

  • Lin-lin Tong
    • 1
  • Peng Gao
    • 1
  • Zhen-ning Wang
    • 1
  • Yong-xi Song
    • 1
  • Ying-ying Xu
    • 1
  • Zhe Sun
    • 1
  • Cheng-zhong Xing
    • 1
  • Xin Wang
    • 1
  • Hui-mian Xu
    • 1
  1. 1.Department of Surgical Oncology and General SurgeryThe First Hospital of China Medical UniversityShenyangPeople’s Republic of China

Personalised recommendations